The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state

• Verfasst von: Maurer, Kurt [VerfasserIn]
• Verfasst von: Zink, Mathias [VerfasserIn]
• Verfasst von: Rausch, Franziska [VerfasserIn]
• Verfasst von: Häfner, Heinz [VerfasserIn]
• Titel: The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state
• Verf.angabe: Kurt Maurer, Mathias Zink, Franziska Rausch and Heinz Häfner
• E-Jahr: 2018
• Jahr: April 2018
• Umfang: 10 S.
• Fussnoten: First published: 23 January 2016 ; Gesehen am 18.10.2019
• Titel Quelle: Enthalten in: Early intervention in psychiatry
• Ort Quelle: Oxford [u.a.] : Wiley-Blackwell, 2007
• Jahr Quelle: 2018
• Band/Heft Quelle: 12(2018), 2, Seite 217-228
• ISSN Quelle: 1751-7893
• DOI: doi:10.1111/eip.12305
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: depression
• Sach-SW: ERIraos
• Sach-SW: prediction of psychosis
• Sach-SW: psychosis risk screening
• Sach-SW: schizophrenia
• K10plus-PPN: 1679123955

Abstract

Aim Functional disability and social consequences frequently occur at the prodromal stage of schizophrenia. Efforts to recognize an increasing risk of psychosis onset have thus become a topical issue worldwide. This is to introduce the English version of the ERIraos early-recognition inventory. Methods The ERIraos, developed in a systematic, empirical approach from the Instrument for the Retrospective Assessment of the Onset of Schizophrenia, incorporates basic symptoms from the Cologne Early Recognition Study. The research version also includes as further predictive items so-called brief limited intermittent psychotic symptoms and attenuated psychotic symptoms from the Comprehensive Assessment of At-Risk Mental States instrument. Results The ERIraos with its 15-item screening Checklist and 50-item Symptom List permits early recognition of psychosis risk in three steps of decreasing sensitivity and increasing specificity. Step 1 relies on patients’ self-perception of symptoms, which prompt them to contact a primary health service. There, in Step 2, at-risk individuals are identified using the Checklist, characterized by a low-risk threshold, and referred to further examination using the Symptom List (Step 3). Information on symptom accumulation and increasing symptom severity enhances the instrument's predictive power. In a validation test, psychotic transitions increased linearly up to 50% over 2 years. Compared with other instruments and on the prodromal stage of depressive disorder, the ERIraos has shown good predictive capacity. Conclusions The ERIraos has been successfully employed as a two-step tool for the early recognition of psychosis risk in several German studies and translated into several foreign languages.